Immunofluorescence imaging revealed an enhanced fluorescent signal of phosphorylated Smad2/Smad3 in breast cancer cells after 3oc treatment (Fig. 2C and SI Appendix, Fig. S6A), and these fluorescent signals were mainly located in the nucleus. Here, SMAD2 is linked to breast carcinoma.